You are currently on the new version of our website. Access the old version .

2,388 Results Found

  • Review
  • Open Access
80 Citations
11,150 Views
36 Pages

20 October 2014

The PI3K/Akt/mTOR pathway plays an essential role in a wide range of biological functions, including metabolism, macromolecular synthesis, cell growth, proliferation and survival. Its versatility, however, makes it a conspicuous target of many patho...

  • Review
  • Open Access
23 Citations
7,745 Views
39 Pages

13 December 2024

Epidermal growth factor receptor 2-positive breast cancer (HER2+ BC) is a highly invasive and malignant type of tumor. Due to its resistance to HER2-targeted therapy, HER2+ BC has a poor prognosis and a tendency for metastasis. Understanding the mech...

  • Review
  • Open Access
109 Citations
12,285 Views
26 Pages

Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer

  • Diana-Theodora Morgos,
  • Constantin Stefani,
  • Daniela Miricescu,
  • Maria Greabu,
  • Silviu Stanciu,
  • Silvia Nica,
  • Iulia-Ioana Stanescu-Spinu,
  • Daniela Gabriela Balan,
  • Andra-Elena Balcangiu-Stroescu and
  • Remus Iulian Nica
  • + 2 authors

3 February 2024

Gastric cancer (GC) is the fourth leading cause of death worldwide, with more than 1 million cases diagnosed every year. Helicobacter pylori represents the main risk factor, being responsible for 78% of the cases. Increased amounts of salt, pickled f...

  • Article
  • Open Access
13 Citations
3,295 Views
18 Pages

Co-Targeting MAP Kinase and Pi3K-Akt-mTOR Pathways in Meningioma: Preclinical Study of Alpelisib and Trametinib

  • Gregoire Mondielli,
  • Gregory Mougel,
  • Florent Darriet,
  • Catherine Roche,
  • Adeline Querdray,
  • Christophe Lisbonis,
  • Romain Appay,
  • Henry Dufour,
  • Olivier Chinot and
  • Anne Barlier
  • + 1 author

13 September 2022

Recurrent or high-grade meningiomas are an unmet medical need. Recently, we demonstrated that targeting mTOR by everolimus was relevant both in vitro and in humans. However, everolimus induces an AKT activation that may impact the anti-proliferative...

  • Article
  • Open Access
35 Citations
5,211 Views
16 Pages

High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors

  • Daniel J. Smit,
  • Laure Cayrefourcq,
  • Marie-Therese Haider,
  • Nico Hinz,
  • Klaus Pantel,
  • Catherine Alix-Panabières and
  • Manfred Jücker

20 September 2020

Circulating tumor cells (CTCs) are cells shed from the primary tumor into the bloodstream. While many studies on solid tumor cells exist, data on CTCs are scarce. The mortality of cancer is mostly associated with metastasis and recent research identi...

  • Review
  • Open Access
188 Citations
24,846 Views
23 Pages

7 July 2014

The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway is one of the key signaling pathways induced by various receptor-tyrosine kinases. Accumulating evidence shows that this pathway is an important promoter of cel...

  • Review
  • Open Access
135 Citations
13,475 Views
16 Pages

The PI3K/Akt Pathway: Emerging Roles in Skin Homeostasis and a Group of Non-Malignant Skin Disorders

  • Yan Teng,
  • Yibin Fan,
  • Jingwen Ma,
  • Wei Lu,
  • Na Liu,
  • Yingfang Chen,
  • Weili Pan and
  • Xiaohua Tao

17 May 2021

The phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway regulates cell proliferation, differentiation, and migration, along with angiogenesis and metabolism. Additionally, it could mediate skin development and homeostasis. T...

  • Article
  • Open Access
19 Citations
4,298 Views
16 Pages

The targeting of the Mitogen-Activated Protein Kinase (MAPK) signalling pathway in melanoma improves the prognosis of patients harbouring the V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) mutation. However, a fraction of these patients may ex...

  • Article
  • Open Access
16 Citations
8,913 Views
20 Pages

Combined Targeting of Estrogen Receptor Alpha and XPO1 Prevent Akt Activation, Remodel Metabolic Pathways and Induce Autophagy to Overcome Tamoxifen Resistance

  • Eylem Kulkoyluoglu-Cotul,
  • Brandi Patrice Smith,
  • Kinga Wrobel,
  • Yiru Chen Zhao,
  • Karen Lee Ann Chen,
  • Kadriye Hieronymi,
  • Ozan Berk Imir,
  • Kevin Duong,
  • Caitlin O’Callaghan and
  • Zeynep Madak-Erdogan
  • + 5 authors

4 April 2019

A majority of breast cancer specific deaths in women with ERα (+) tumors occur due to metastases that are resistant to endocrine therapy. There is a critical need for novel therapeutic approaches to resensitize recurrent ERα (+) tumors to...

  • Article
  • Open Access
39 Citations
8,146 Views
17 Pages

2 April 2013

Hamacanthins, bis (indole) alkaloids, are found in a few marine sponges, including Spongosorites sp. Hamacanthins have been shown to possess cytotoxic, antibacterial and antifungal activities. However, the precise mechanism for the biological activit...

  • Article
  • Open Access
10 Citations
3,172 Views
11 Pages

26 September 2020

Pancreatic ductal adenocarcinoma (PDAC) is the most aggressive tumor malignancy worldwide, mainly due to uncontrolled metastasis. Among the numerous molecules deregulated in PDAC, different members of the Akt pathways are of great importance because...

  • Review
  • Open Access
104 Citations
16,603 Views
66 Pages

The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds

  • Tithi Roy,
  • Samuel T. Boateng,
  • Mohammad B. Uddin,
  • Sergette Banang-Mbeumi,
  • Rajesh K. Yadav,
  • Chelsea R. Bock,
  • Joy T. Folahan,
  • Xavier Siwe-Noundou,
  • Anthony L. Walker and
  • Jean Christopher Chamcheu
  • + 3 authors

20 June 2023

The dysregulated phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin (mTOR) signaling pathway has been implicated in various immune-mediated inflammatory and hyperproliferative dermatoses such as acne, atopic dermatitis, alopecia,...

  • Review
  • Open Access
8 Citations
5,236 Views
20 Pages

Redefining Therapeutic Approaches in Colorectal Cancer: Targeting Molecular Pathways and Overcoming Resistance

  • Simona Gabriela Duta-Ion,
  • Ioana Ruxandra Juganaru,
  • Iulian Andrei Hotinceanu,
  • Andra Dan,
  • Livia Malina Burtavel,
  • Madalin Codrut Coman,
  • Ina Ofelia Focsa,
  • Andra Giorgiana Zaruha,
  • Patricia Christina Codreanu and
  • Viorica Elena Radoi
  • + 1 author

21 November 2024

Colorectal cancer (CRC) arises through a combination of genetic and epigenetic alterations that affect key pathways involved in tumor growth and progression. This review examines the major molecular pathways driving CRC, including Chromosomal Instabi...

  • Article
  • Open Access
16 Citations
4,296 Views
21 Pages

Circulating miR-1246 Targeting UBE2C, TNNI3, TRAIP, UCHL1 Genes and Key Pathways as a Potential Biomarker for Lung Adenocarcinoma: Integrated Biological Network Analysis

  • Siyuan Huang,
  • Yong-Kai Wei,
  • Satyavani Kaliamurthi,
  • Yanghui Cao,
  • Asma Sindhoo Nangraj,
  • Xin Sui,
  • Dan Chu,
  • Huan Wang,
  • Dong-Qing Wei and
  • Jiang Shi
  • + 2 authors

11 October 2020

Analysis of circulating miRNAs (cmiRNAs) before surgical operation (BSO) and after the surgical operation (ASO) has been informative for lung adenocarcinoma (LUAD) diagnosis, progression, and outcomes of treatment. Thus, we performed a biological net...

  • Article
  • Open Access
21 Citations
3,444 Views
22 Pages

Shikonin Causes an Apoptotic Effect on Human Kidney Cancer Cells through Ras/MAPK and PI3K/AKT Pathways

  • József Király,
  • Erzsébet Szabó,
  • Petra Fodor,
  • Zsolt Fejes,
  • Béla Nagy,
  • Éva Juhász,
  • Anna Vass,
  • Mahua Choudhury,
  • Gábor Kónya and
  • Zsuzsanna Szabó
  • + 1 author

20 September 2023

(1) Background: Shikonin, the main ingredient in Chinese herbal medicine, is described as a novel angiogenesis inhibitor, and its anticancer effects have already been studied. Shikonin and its derivatives induce apoptosis and suppress metastasis, whi...

  • Article
  • Open Access
1,628 Views
17 Pages

Exosomal miR-7-25207 Increases Subgroup J Avian Leukosis Virus Titers by Targeting the Akt-CyclinQ1 and PRC1-YAF2 Dual Pathways

  • Xiaona Zeng,
  • Tongfei Liu,
  • Shengqiu Tang,
  • Xiaoying Dong,
  • Yajuan Li,
  • Liqin Liao,
  • Sheng Chen,
  • Liyi Chen,
  • Jie Kong and
  • Qingmei Xie
  • + 3 authors

Subgroup J avian leukosis virus (ALV-J) is a major pathogen in poultry, causing substantial economic losses to the poultry industry worldwide. Exosomal small RNAs derived from virus-infected cells or biological fluids can serve as viral transmission...

  • Article
  • Open Access
12 Citations
4,383 Views
16 Pages

Silencing DTX3L Inhibits the Progression of Cervical Carcinoma by Regulating PI3K/AKT/mTOR Signaling Pathway

  • Wei Hu,
  • Yaorui Hu,
  • Yao Pei,
  • Rongrong Li,
  • Fuyi Xu,
  • Xiaodong Chi,
  • Jia Mi,
  • Jonas Bergquist,
  • Lu Lu and
  • Chunhua Yang
  • + 1 author

Cervical carcinoma (CC) is the second most prevalent gynecologic cancer in females across the world. To obtain a better understanding of the mechanisms underlying the development of CC, high-resolution label-free mass spectrometry was performed on CC...

  • Review
  • Open Access
1 Citations
3,913 Views
27 Pages

Gliomas are the most common and lethal malignant primary brain tumors in adults, associated with the highest number of years of potential life lost. The latest WHO classification for central nervous system tumors highlighted the need for new biomarke...

  • Review
  • Open Access
5 Citations
2,372 Views
21 Pages

23 January 2025

Epithelial-to-mesenchymal transition (EMT) is a critical process in malignant ovarian cancer metastasis. EMT involves the conversion of epithelial cells to mesenchymal cells, conferring enhanced migratory and invasive capabilities. Glioblastoma multi...

  • Review
  • Open Access
2,594 Views
34 Pages

Neurotransmitter Regulatory Networks: A New Perspective on Cancer Therapy

  • Xiaoyu Zhang,
  • Jiaxin Cao,
  • Yishu Zhang,
  • Chuanxiong Li and
  • Yuhong Jing

9 October 2025

In recent years, the scientific community has increasingly delved into the study of the interaction between the nervous system and tumors, revealing that the nervous system not only regulates bodily functions under physiological conditions, but also...

  • Article
  • Open Access
1,381 Views
19 Pages

Mortalin Represents a Promising Therapeutic Target for Oral Cancers: Clinical Relevance and Experimental Evidence for the Activation of Akt/mTOR Signaling

  • Sosmitha Girisa,
  • Mangala Hegde,
  • Choudhary Harsha,
  • Nafiseh Manteghi,
  • Imliwati Longkumer,
  • Gazi Naseem Ahmed,
  • Munindra Narayan Baruah,
  • Sunil C. Kaul,
  • Renu Wadhwa and
  • Ajaikumar B. Kunnumakkara

30 August 2025

Background: Oral cancer remains a significant global health concern due to its high incidence and mortality, as highlighted by GLOBOCAN 2022, and is characterized by poor survival rates despite available therapies. Therefore, there is an imperative n...

  • Article
  • Open Access
1,606 Views
14 Pages

Glabridin Alleviates Oxidative Stress-Induced Osteoporosis by Targeting the Akt/NF-ĸB and Akt/GSK-3β Pathways

  • Chittipong Tipbunjong,
  • Wipapan Khimmaktong,
  • Tanaporn Hengpratom,
  • Thanvarin Thitiphatphuvanon,
  • Chumpol Pholpramool and
  • Piyaporn Surinlert

Diabetes-related osteoporosis has been known to be a consequence of oxidative stress caused by excessive reactive oxygen species (ROS) production in the tissues. Despite the increase in the number of individuals with diabetes-related osteoporosis yea...

  • Review
  • Open Access
17 Citations
4,519 Views
27 Pages

Modulation of AKT Pathway-Targeting miRNAs for Cancer Cell Treatment with Natural Products

  • Jun-Ping Shiau,
  • Ya-Ting Chuang,
  • Ching-Yu Yen,
  • Fang-Rong Chang,
  • Kun-Han Yang,
  • Ming-Feng Hou,
  • Jen-Yang Tang and
  • Hsueh-Wei Chang

12 February 2023

Many miRNAs are known to target the AKT serine-threonine kinase (AKT) pathway, which is critical for the regulation of several cell functions in cancer cell development. Many natural products exhibiting anticancer effects have been reported, but thei...

  • Review
  • Open Access
10 Citations
5,846 Views
18 Pages

3 July 2025

Triple-negative breast cancer is the most aggressive subtype of breast cancer and is associated with the worst prognosis. Conventional chemotherapy remains the gold standard treatment for this disease but is associated with a high relapse rate, highl...

  • Review
  • Open Access
103 Citations
18,094 Views
20 Pages

In the last decade, pathway-specific targeted therapy has revolutionized colorectal cancer (CRC) treatment strategies. This type of therapy targets a tumor-vulnerable spot formed primarily due to an alteration in an oncogene and/or a tumor suppressor...

  • Article
  • Open Access
63 Citations
4,434 Views
14 Pages

Curcumin and Plumbagin Synergistically Target the PI3K/Akt/mTOR Pathway: A Prospective Role in Cancer Treatment

  • Iftikhar Ahmad,
  • Mehboob Hoque,
  • Syed Sahajada Mahafujul Alam,
  • Torki A. Zughaibi and
  • Shams Tabrez

Cancer development is associated with the deregulation of various cell signaling pathways brought on by certain genetic and epigenetic alterations. Therefore, novel therapeutic strategies have been developed to target those pathways. The phosphoinosi...

  • Review
  • Open Access
212 Citations
17,216 Views
20 Pages

Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma

  • Eun Jin Sun,
  • Miriam Wankell,
  • Pranavan Palamuthusingam,
  • Craig McFarlane and
  • Lionel Hebbard

Despite advances in the treatment of cancers through surgical procedures and new pharmaceuticals, the treatment of hepatocellular carcinoma (HCC) remains challenging as reflected by low survival rates. The PI3K/Akt/mTOR pathway is an important signal...

  • Article
  • Open Access
9 Citations
3,169 Views
17 Pages

8 April 2024

Eriocitrin, a flavanone found in peppermint and citrus fruits, is known to possess many physiological activities. However, the anti-angiogenic effects of eriocitrin are yet to be fully elucidated. Therefore, the objective of this research was to expl...

  • Article
  • Open Access
11 Citations
4,242 Views
17 Pages

Baicalin Targets HSP70/90 to Regulate PKR/PI3K/AKT/eNOS Signaling Pathways

  • Yinzhu Hou,
  • Zuqing Liang,
  • Luyu Qi,
  • Chao Tang,
  • Xingkai Liu,
  • Jilin Tang,
  • Yao Zhao,
  • Yanyan Zhang,
  • Tiantian Fang and
  • Fuyi Wang
  • + 2 authors

21 February 2022

Baicalin is a major active ingredient of traditional Chinese medicine Scutellaria baicalensis, and has been shown to have antiviral, anti-inflammatory, and antitumor activities. However, the protein targets of baicalin have remained unclear. Herein,...

  • Commentary
  • Open Access
9 Citations
2,892 Views
10 Pages

Co-Targeting the EGFR and PI3K/Akt Pathway to Overcome Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma: What about Autophagy?

  • Hannah Zaryouh,
  • Jinthe Van Loenhout,
  • Marc Peeters,
  • Jan Baptist Vermorken,
  • Filip Lardon and
  • An Wouters

12 December 2022

Resistance to EGFR-targeted therapy is a major obstacle on the road to effective treatment options for head and neck cancers. During the search for underlying mechanisms and regulators of this resistance, there were several indications that EGFR-targ...

  • Review
  • Open Access
50 Citations
15,594 Views
10 Pages

Targeting PI3K/AKT/mTOR Signaling Pathway as a Radiosensitization in Head and Neck Squamous Cell Carcinomas

  • Yu-Chieh Su,
  • Wei-Chang Lee,
  • Chih-Chun Wang,
  • Shyh-An Yeh,
  • Wen-Hui Chen and
  • Po-Jen Chen

12 December 2022

Globally, there are over half a million new patients with head and neck squamous cell carcinomas (HNSCC) every year. The current therapeutic approaches to HNSCC are surgery and adjuvant radiotherapy. These approaches carry a high incidence of metasta...

  • Review
  • Open Access
154 Citations
16,038 Views
19 Pages

Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer

  • Huayi Li,
  • Lorenzo Prever,
  • Emilio Hirsch and
  • Federico Gulluni

14 July 2021

Breast cancer is the most frequently diagnosed cancer and the primary cause of cancer death in women worldwide. Although early diagnosis and cancer growth inhibition has significantly improved breast cancer survival rate over the years, there is a cu...

  • Review
  • Open Access
25 Citations
12,508 Views
18 Pages

18 June 2024

The PI3K/AKT/mTOR signalling pathway is one of the most frequently activated pathways in breast cancer and also plays a central role in the regulation of several physiologic functions. There are major efforts ongoing to exploit precision medicine by...

  • Review
  • Open Access
175 Citations
26,966 Views
27 Pages

Lung cancer is one of the most common cancers and has a high mortality rate. Due to its high incidence, the clinical management of the disease remains a major challenge. Several reports have documented a relationship between the phosphatidylinositol-...

  • Article
  • Open Access
1 Citations
1,047 Views
17 Pages

11 October 2025

Background: Isorhamnetin (ISO), a dietary O-methylated flavonol, was evaluated for hypoglycemic activity and mechanism in a streptozotocin (STZ) model of type 1 diabetes. Methods: We conducted untargeted plasma metabolomics (ESI±), network int...

  • Article
  • Open Access
13 Citations
6,518 Views
18 Pages

Assessment of PI3K/mTOR/AKT Pathway Elements to Serve as Biomarkers and Therapeutic Targets in Penile Cancer

  • Anita Thomas,
  • Sascha Reetz,
  • Philipp Stenzel,
  • Katrin Tagscherer,
  • Wilfried Roth,
  • Mario Schindeldecker,
  • Martin Michaelis,
  • Florian Rothweiler,
  • Jindrich Cinatl and
  • Igor Tsaur
  • + 8 authors

12 May 2021

The PI3K/mTOR/AKT pathway might represent an intriguing option for treatment of penile cancer (PeCa). We aimed to assess whether members of this pathway might serve as biomarkers and targets for systemic therapy. Tissue of primary cancer from treatme...

  • Article
  • Open Access
24 Citations
6,259 Views
11 Pages

Leptin Modulates the Expression of miRNAs-Targeting POMC mRNA by the JAK2-STAT3 and PI3K-Akt Pathways

  • Adel Derghal,
  • Julien Astier,
  • Flavie Sicard,
  • Charlène Couturier,
  • Jean-François Landrier and
  • Lourdes Mounien

14 December 2019

The central control of energy balance involves a strongly regulated neuronal network within the hypothalamus and the brainstem. In these structures, pro-opiomelanocortin (POMC) neurons are known to decrease food intake and to increase energy expendit...

  • Review
  • Open Access
191 Citations
14,970 Views
32 Pages

Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma

  • Amir Barzegar Behrooz,
  • Zahra Talaie,
  • Fatemeh Jusheghani,
  • Marek J. Łos,
  • Thomas Klonisch and
  • Saeid Ghavami

25 January 2022

Glioblastoma (GBM) is a devastating type of brain tumor, and current therapeutic treatments, including surgery, chemotherapy, and radiation, are palliative at best. The design of effective and targeted chemotherapeutic strategies for the treatment of...

  • Review
  • Open Access
70 Citations
9,168 Views
17 Pages

Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges

  • Krisida Cerma,
  • Federico Piacentini,
  • Luca Moscetti,
  • Monica Barbolini,
  • Fabio Canino,
  • Antonio Tornincasa,
  • Federica Caggia,
  • Sara Cerri,
  • Alessia Molinaro and
  • Claudia Omarini
  • + 1 author

Breast cancer (BC) is the most common women cancer and cause of cancer death. Despite decades of scientific progress in BC treatments, the clinical benefit of new drugs is modest in several cases. The phosphatidylinositol 3-kinase (PI3K)/protein kina...

  • Review
  • Open Access
132 Citations
18,028 Views
26 Pages

5 July 2019

Ovarian cancer is the most lethal gynecologic malignancy in the United States, with an estimated 22,530 new cases and 13,980 deaths in 2019. Recent studies have indicated that the phosphoinositol 3 kinase (PI3K)/protein kinase B (AKT)/mammalian targe...

  • Article
  • Open Access
1,323 Views
17 Pages

28 August 2025

Non-small cell lung cancer (NSCLC) remains one of the leading causes of cancer-related mortality, with resistance to chemotherapy representing a major therapeutic challenge. In this study, we investigated the effects of conventional chemotherapeutics...

  • Article
  • Open Access
17 Citations
4,558 Views
24 Pages

Targeting SIRT1/FoxO3a/Nrf2 and PI3K/AKT Pathways with Rebamipide Attenuates Acetic Acid-Induced Colitis in Rats

  • Maha M. Abdel-Fattah,
  • Emad H. M. Hassanein,
  • Ahmed M. Sayed,
  • Shuruq E. Alsufyani,
  • Azza A. K. El-Sheikh,
  • Hany H. Arab and
  • Wafaa R. Mohamed

Rebamipide is a quinolone derivative that has been commonly used for the treatment of gastric and duodenal ulcers. However, the molecular mechanisms of rebamipide against acetic acid-evoked colitis have not been adequately examined. Hence, the curren...

  • Article
  • Open Access
64 Citations
10,196 Views
19 Pages

The mitogen-activated protein kinase (MAPK)/extracellular signal kinase (ERK) and phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signal transduction pathways have been implicated in the pathogenesis of leukemia. The aim of this study was...

  • Review
  • Open Access
107 Citations
8,936 Views
25 Pages

Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects

  • Silviu Stanciu,
  • Florentina Ionita-Radu,
  • Constantin Stefani,
  • Daniela Miricescu,
  • Iulia-Ioana Stanescu-Spinu,
  • Maria Greabu,
  • Alexandra Ripszky Totan and
  • Mariana Jinga

4 September 2022

Although pancreatic cancer (PC) was considered in the past an orphan cancer type due to its low incidence, it may become in the future one of the leading causes of cancer death. Pancreatic ductal adenocarcinoma (PDAC) is the most frequent type of PC,...

  • Review
  • Open Access
171 Citations
15,756 Views
33 Pages

Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy

  • Jean Christopher Chamcheu,
  • Tithi Roy,
  • Mohammad Burhan Uddin,
  • Sergette Banang-Mbeumi,
  • Roxane-Cherille N. Chamcheu,
  • Anthony L. Walker,
  • Yong-Yu Liu and
  • Shile Huang

31 July 2019

The mammalian or mechanistic target of rapamycin (mTOR) and associated phosphatidyl-inositiol 3-kinase (PI3K)/protein kinase B (Akt) pathways regulate cell growth, differentiation, migration, and survival, as well as angiogenesis and metabolism. Dysr...

  • Review
  • Open Access
29 Citations
7,400 Views
17 Pages

PI3K/Akt Pathway: The Indestructible Role of a Vintage Target as a Support to the Most Recent Immunotherapeutic Approaches

  • Matteo Caforio,
  • Emmanuel de Billy,
  • Biagio De Angelis,
  • Stefano Iacovelli,
  • Concetta Quintarelli,
  • Valeria Paganelli and
  • Valentina Folgiero

11 August 2021

Pathologic activation of PI3Ks and the subsequent deregulation of its downstream signaling pathway is among the most frequent events associated with cellular transformation, cancer, and metastasis. PI3Ks are also emerging as critical factors in regul...

  • Article
  • Open Access
15 Citations
2,938 Views
16 Pages

STIL Promotes Tumorigenesis of Bladder Cancer by Activating PI3K/AKT/mTOR Signaling Pathway and Targeting C-Myc

  • Hua Yu,
  • Liang Chen,
  • Xia Wang,
  • Feng Tang,
  • Ziyu Wan,
  • Hao Wang,
  • Qiqi Fu,
  • Zhizhuang Chen,
  • Jiageng Shi and
  • Jianping Peng
  • + 5 authors

24 November 2022

SCL/TAL1 interrupting locus (STIL) regulates centriole replication and causes chromosome instability, which is closely related to malignant tumors. The purpose of our study was to investigate the role of STIL in bladder cancer (BC) tumorigenesis for...

  • Article
  • Open Access
17 Citations
4,265 Views
20 Pages

JIB-04, a pan-histone lysine demethylase (KDM) inhibitor, targets drug-resistant cells, along with colorectal cancer stem cells (CSCs), which are crucial for cancer recurrence and metastasis. Despite the advances in CSC biology, the effect of JIB-04...

  • Article
  • Open Access
3,635 Views
15 Pages

Calliviminone A from Callistemon citrinus Induces PANC-1 Pancreatic Cancer Cell Death by Targeting the PI3K/Akt/mTOR Pathway

  • Juthamart Maneenet,
  • Ahmed M. Tawila,
  • Hung Hong Nguyen,
  • Nguyen Duy Phan,
  • Orawan Monthakantirat,
  • Supawadee Daodee,
  • Chantana Boonyarat,
  • Charinya Khamphukdee,
  • Yaowared Chulikhit and
  • Suresh Awale

7 July 2025

Pancreatic cancer cells exhibit a remarkable ability to tolerate nutrient deprivation, a phenomenon termed “austerity,” which enables their survival within the hypovascular tumor microenvironment. Conventional anticancer therapies frequen...

  • Review
  • Open Access
184 Views
26 Pages

13 January 2026

Background: Canine mammary carcinoma (CMC) is the most common malignant tumour in female dogs and, due to its similarities, is a valuable comparative model for human breast cancer. Kinase inhibitors have revolutionised the treatment of human breast c...

of 48